Research Progress on Depression Fatigue

doi:10.12114/j.issn.1007-9572.2019.00.321

Abstract

Abstract: The relationship between fatigue and depression is very complex.As a symptom of depression，fatigue is a common premonitory symptom especially at the first attack of the depression.Fatigue is also a residual symptom of depression which is more prone to become chronic disease than other depressive symptoms and is highly related to patients' work and social function defects.Therefore，paying attention to fatigue of depressive patients has important significance for their clinical treatment，the improvement of their quality of life and the reduction of recurrence rate of depression.This article reviews the definition，clinical manifestation，adverse outcomes，mechanism，diagnosis and treatment of depression fatigue in order to provide a reference for doctors.

Key words: Fatigue, Depressive disorder, Signs and symptoms, Quality of life, Review

摘要： 疲劳感与抑郁症的关系十分复杂，其是抑郁症的一种常见症状；是一种普遍的抑郁症前驱症状，尤其是抑郁症首次发作时；也是抑郁症的一种残留症状，并且比其他抑郁症状更易趋于慢性化，与患者工作和社会功能缺损高度相关。因此，关注抑郁症患者的疲劳感症状对临床治疗抑郁症、改善患者的生活质量及降低复发率具有重要的临床意义。本文就抑郁症相关疲劳感的定义、临床表现、不良后果、产生机制、诊治进展进行综述，以期为广大医生提供参考。

关键词: 疲劳感, 抑郁症, 体征和症状, 生活质量, 综述

LI Miao,WANG Qunsong,JIA Hongxiao. Research Progress on Depression Fatigue　[J]. Chinese General Practice, 2019, 22(31): 3901-3904. DOI: 10.12114/j.issn.1007-9572.2019.00.321.
李苗,王群松,贾竑晓. 抑郁症相关疲劳感的研究进展[J]. 中国全科医学, 2019, 22(31): 3901-3904. DOI: 10.12114/j.issn.1007-9572.2019.00.321.

References

［1］World Health Organization. ICD-10精神与行为障碍分类［M］．范肖东，汪向东，于欣，等，译.北京：人民卫生出版社，1993：97-98.
［2］American Psychiatric Association.Diagnostic and statistical manual of mental disorders［M］．Washington DC：American Psychiatric Association，2013：163-164.
［3］SIU A L，US Preventive Services Task Force（USPSTF），BIBBINS-DOMINGO K，et al．Screening for depression in adults US Preventive Services Task Force recommendation statement［J］．JAMA，2016，315（4）：380-387．DOI：10.1001/jama.2015.18392.
［4］ADDINGTON A M，GALLO J J，FORD D E，et al．Epidemiology of unexplained fatigue and major depression in the community：the baltimore ECA follow-up，1981—1994［J］．Psychol Med，2001，31（6）：1037-1044．DOI：10.1017/s0033291701004214.
［5］ARNOLD L M．Understanding fatigue in major depressive disorder and other medical disorders［J］．Psychosomatics，2008，49（3）：185-190．DOI：10.1176/appi.psy.49.3.185.
［6］NYER M，MISCHOULON D，ALPERT J E，et al．College students with depressive symptoms with and without fatigue：differences in functioning，suicidality，anxiety，and depressive severity［J］．Ann Clin Psychiatry，2015，27（2）：100-108.
［7］TRIVEDI M H，RUSH A J，WISNIEWSKI S R，et al．Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D：implications for clinical practice［J］．Am J Psychiatry，2006，163（1）：28-40．DOI：10.1176/appi.ajp.163.1.28.
［8］GREENBERG P E，FOURNIER A A，SISITSKY T，et al．The economic burden of adults with major depressive disorder in the United States （2005 and 2010）［J］．J Clin Psychiatry，2015，76（2）：155-162．DOI：10.4088/JCP.14m09298.
［9］ROBINSON R L，STEPHENSON J J，DENNEHY E B，et al．The importance of unresolved fatigue in depression：costs and comorbidities［J］．Psychosomatics，2015，56（3）：274-285．DOI：10.1016/j.psym.2014.08.003.
［10］ROBINSON R L，GRABNER M，PALLI S R，et al．Covariates of depression and high utilizers of healthcare：impact on resource use and costs［J］．J Psychosom Res，2016，85：35-43．DOI：10.1016/j.jpsychores.2016.04.002.
［11］STAHL S M，ZHANG L，DAMATARCA C，et al．Brain circuits determine destiny in depression：a novel approach to the psychopharmacology of wakefulness，fatigue，and executive dysfunction in major depressive disorder［J］．J Clin Psychiatry，2003，64（suppl 14）：6-17．DOI：10.1007/S00357-003-0016-2.
［12］FAVA M，BALL S，NELSON J C，et al．Clinical relevance of fatigue as a residual symptom in major depressive disorder［J］．Depress Anxiety，2014，31（3）：250-257．DOI：10.1002/da.22199.
［13］ANISMAN H，MERALI Z，POULTER M O，et al．Cytokines as a precipitant of depressive illness：animal and human studies［J］．Curr Pharm Des，2005，11（8）：963-972．DOI：10.2174/1381612053381701．
［14］SIMON N M，MCNAMARA K，CHOW C W，et al．A detailed examination of cytokine abnormalities in major depressive disorder［J］．Eur Neuropsychopharmacol，2008，18（3）：230-233．DOI：10.1016/j.euroneuro.2007.06.004.
［15］MCCLINTOCK S M，HUSAIN M M，WISNIEWSKI S R，et al．Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication［J］．J Clin Psychopharmacol，2011，31（2）：180-186．DOI：10.1097/jcp.0b013e31820ebd2c.
［16］BALDWIN D S，PAPAKOSTAS G I．Symptoms of fatigue and sleepiness in major depressive disorder［J］．J Clin Psychiatry，2006，67：9-15．DOI：10.1080/13803390590929298.
［17］SCHWEITZER P K．Principles and practice of sleep medicine［M］．6th ed．Philadelphia：PA，2017：480-498.
［18］FERENTINOS P P，KONTAXAKIS V P，HAVAKI-KONTAXAKI B J，et al．The measurement of fatigue in depression［J］．Psychopathology，2007，40（2）：133-134．DOI：10.1159/000098494.
［19］MATZA L S，WYRWICH K W，PHILLIPS G A，et al．The fatigue associated with depression scale：responsiveness and responder definition［J］．Qual Life Res，2013，22（2）：351-360．DOI：10.1007/s11136-012-0142-6.
［20］COOPER J A，TUCKER V L．Resolution of sleepiness and fatigue：a comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union［J］．J Psychopharmacol，2014，28（2）：118-124．DOI：10.1177/0269881113514878.
［21］DEBATTISTA C，DOGHRAMJI K，MENZA M A，et al．Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder：a preliminary doubleblind placebo-controlled study［J］．J Clin Psychiatry，2003，64（9）：1057-1064．DOI：10.1111/1469-7610.00176_12.
［22］FAVA M，THASE M E，DEBATTISTA C．A multicenter，placebocontrolled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness［J］．J Clin Psychiatry，2005，66（1）：85-93．DOI：10.0000/PMID15669893.

[1]	JIAO Shuting, JING Haoran, ZHAO Yali. The Severity and Influencing Factors of Chronic Pruritus Symptoms in Elderly Patients Seeking Medical Treatment in Urban Communities in Beijing [J]. Chinese General Practice, 2026, 29(25): 3655-3663.
[2]	LI Jia, HE Jun, ZHU Jinmei, LIU Fuming, WU Yuan, DING Yuquan, QIAN Hua, XU Xinyu. Effects of Low-volume High-intensity Interval Training Combined with Virtual Reality Technology on Cardiac Rehabilitation in Patients with Coronary Heart Disease [J]. Chinese General Practice, 2026, 29(25): 3640-3649.
[3]	QI Jing, CAI Qing, ZHANG Wanting, GU Yan. A WeChat Mini-program-based Telerehabilitation Program for Stable COPD: Multidimensional Efficacy and Adherence Study [J]. Chinese General Practice, 2026, 29(24): 3476-3485.
[4]	YAN Wen, ZHANG Hanzhi, JIN Hua, QIAN Jie, YU Dehua. Study on the Diagnosis and Treatment Capacity for Depressive Disorders in Community Health Service Institutions in Shanghai [J]. Chinese General Practice, 2026, 29(20): 2790-2799.
[5]	NIE Jiahui, LI Guojuan, HAO Zhuoqun, DU Qiaorong, LIU Penghong, LIU Zhifen, LIU Sha, ZHANG Aixia, WANG Yanfang. Heterogeneity and Influencing Factors of Cognitive Function Impairment in Patients with Major Depressive Disorder [J]. Chinese General Practice, 2026, 29(17): 2340-2346.
[6]	WU Ruining, ZHOU Ming, ZHANG Gongzi, LI Jun, XIE Suhang, LIU Yangxiaoxue, ZHANG Jiali, LIU Maomao, HUANG Liping. Study on Fixed and Mobile Exoskeleton Robots in Improving Lower Limb Function and Quality of Life in Stroke Patients: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(17): 2326-2333.
[7]	YU Chao, SONG Lihua, WANG Linyan, LU Yunping, WANG Linyang, CUI Wei. The Functional Outcomes and Influencing Factors in Patients with First-episode Major Depressive Disorder after 7 Years [J]. Chinese General Practice, 2026, 29(16): 2221-2226.
[8]	YAO Dingye, LUO Guiping, SUN Junsheng, LI Hui. Research Progress on Identifying Bipolar Ⅱ Disorder and Depressive Disorder in Primary Care [J]. Chinese General Practice, 2026, 29(15): 2092-2099.
[9]	DUAN Ruolan, QIU Jiamei, YANG Changyuan, LI Qin, MO Haoyu, PI Minhui, YANG Zhenhua, XIA Ai, ZHANG La, LIU Xusheng, LU Fuhua, HOU Haijing, SU Guobin. Assessment of Fatigue in Patients with Chronic Kidney Disease: the Choice of Patient-reported Outcome Measures Scales [J]. Chinese General Practice, 2026, 29(13): 1784-1792.
[10]	CAI Dongping, REN Wen, REN Jingjing. Features of Fatigue Patients from the General Practice Department of a General Hospital [J]. Chinese General Practice, 2026, 29(10): 1334-1339.
[11]	HU Qi, XU Ning, MA Ximin, HE Jiahui, QIAO Hui. The Health-related Quality of Life of Rural Women in the Southern Mountainous Regions of Ningxia Hui Autonomous Region and Its Impact on the Utilization of Health Services [J]. Chinese General Practice, 2026, 29(08): 988-996.
[12]	ZHOU Hongmei, HE Lin, XU Hui, WANG Ning. A Systematic Review of Fatigue Assessment Tools for Cancer Patients Based on the COSMIN Guidelines [J]. Chinese General Practice, 2026, 29(08): 965-973.
[13]	JIANG Xuan, CHEN Yinhai, LU Yuanwei, ZHANG Jiali, LIN Congxuan, KE Xiong. Impact of Childhood Adverse Experiences on Health-related Quality of Life in Adulthood: a Mediating Role of the Number of Chronic Diseases [J]. Chinese General Practice, 2026, 29(07): 893-899.
[14]	REN Panpan, JIA Changli, JIA Jingjing, XU Jinglin, CHEN Mengyao, ZHANG Xiang. The Impact of Livelihood Capitals on the Quality of Life of Rural Older Adults: a Study Based on Different Chronic Disease Conditions [J]. Chinese General Practice, 2026, 29(01): 129-136.
[15]	WANG Lizhu, LI Sihan, WANG Xinyi, MAO Sunxi, QIU Yang, WANG Zhonghua. Pathway Analysis of the Impact of Diabetes Knowledge and Self-efficacy on Self-management and Quality of Survival among Rural Patients with Type 2 Diabetes Mellitus Based on ITHBC Modeling [J]. Chinese General Practice, 2025, 28(34): 4351-4358.